Radiotherapy quality assurance for the RTOG 0834/EORTC 26053-22054/NCIC CTG CEC.1/CATNON intergroup trial "concurrent and adjuvant temozolomide chemotherapy in newly diagnosed non-1p/19q deleted anaplastic glioma": Individual case review analysis. [electronic resource]
Producer: 20181109Description: 292-298 p. digitalISSN:- 1879-0887
- Antineoplastic Agents, Alkylating -- therapeutic use
- Brain Neoplasms -- drug therapy
- Chemotherapy, Adjuvant
- Chromosome Deletion
- Chromosomes, Human, Pair 1
- Chromosomes, Human, Pair 19
- Dacarbazine -- analogs & derivatives
- Glioma -- drug therapy
- Humans
- Prospective Studies
- Quality Assurance, Health Care
- Radiotherapy Planning, Computer-Assisted -- methods
- Retrospective Studies
- Temozolomide
- Tomography, X-Ray Computed -- methods
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.